Pfizer Q4 2022 Earnings Teleconference | January 2023

Pfizer's fourth quarter 2022 earnings teleconference presentation delivered January 31, 2023, includes forward-looking statements on financial performance, product pipeline developments, and strategic initiatives. The presentation discusses COVID-19 vaccine and treatment contributions, including Comirnaty and Paxlovid, alongside broader pharmaceutical portfolio performance and operational updates.